Adjuvant ALK Inhibitors Reshape Care After Resection in ALK-Positive Lung Cancer
A narrative review analyzes adjuvant ALK inhibition trials in resected non-small cell lung cancer alongside emerging perioperative and translational evidence.
Tag: ALINA trial
POPULAR NEWS
-
One in Five Adolescents in Asian Birth Cohort Engaged in Repeated Self-Harm by Age 13
-
Baicalein Identified as Direct IDO1 Inhibitor in Ulcerative Colitis
-
Indicator-Based Review Assesses Policy Gaps in Iran’s Brucellosis Control Program
-
Humic Substances Boost Passion Fruit Seedling Vigor Only Alongside Mineral Fertilization